siRNA CNS Silencing

Small interfering RNA (siRNA) are double-stranded RNA molecules that operate in the RNA interference pathway. Here is the latest research on silencing of genes in the central nervous system using siRNAs.

January 9, 2021

Autophagy-Dependent Increased ADAM10 Mature Protein Induced by TFEB Overexpression Is Mediated Through PPARα

Molecular Neurobiology
Hongjie WangMadepalli K Lakshmana
January 8, 2021

Tyrosine kinase Fyn promotes apoptosis after intracerebral hemorrhage in rats by activating Drp1 signaling

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Li ZhangPing Liang
January 22, 2021

CHRNA1 promotes the pathogenesis of primary focal hyperhidrosis.

Molecular and Cellular Neurosciences
Jian-Bo LinFan-Cai Lai
January 15, 2021

GRK2 mediates β-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis

Journal of Virology
Colleen L MayberryMelissa S Maginnis
January 16, 2021
Open Access

Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma

Journal of Cellular and Molecular Medicine
Jing ZhouWeiwei Zhang
January 23, 2021

Fragment-based nuclear magnetic resonance screen against a Regulator of G Protein Signaling identifies a binding "hot spot".

Chembiochem : a European Journal of Chemical Biology
Michael P HayesJonathan A Doorn
January 13, 2021
Open Access

Cholesterol synthesis inhibition promotes axonal regeneration in the injured central nervous system.

Neurobiology of Disease
Alireza P ShabanzadehPhilippe P Monnier
January 17, 2021

Disruption of the cytochrome P450 CYP6BQ7 gene reduces tolerance to plant toxicants in the red flour beetle, Tribolium castaneum.

International Journal of Biological Macromolecules
Yuan-Chen ZhangKun-Peng Zhang
January 8, 2021
Open Access

The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells.

The Journal of Biological Chemistry
Evan P BooySean A McKenna
January 20, 2021

Quantification of Amyloid-β in Plasma by Simple and Highly Sensitive Immunoaffinity Enrichment and LC-MS/MS Assay

The Journal of Applied Laboratory Medicine
Takuya IinoTomokazu Yoshida

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

© 2021 Meta ULC. All rights reserved
/feed-previews/sirna-cns-silencing/d2af41f8-e378-4259-872f-6d443540346c